InsidersTradesSigma
Total declarations
Company
▲ Purchases (4 ops.)
▼ Sales (7 ops.)
Insider track record
ExecutiveDisclosed buys
4
Disclosed sells
7
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Signal history
Discover the detailed record of transactions filed by Wettig Thane, Directeur Commercial. Insider active across 1 company, notably FIBROGEN INC. Cumulatively, 43 filings have been logged. Split: 4 buys · 7 sells. Total volume traded: €380k. Activity tracked since 22 June 2021. The latest transaction was disclosed on 24 March 2025 (Acquisition). Regulator: SEC (Form 4). The full history is openly available.
Declarations43 total
145,000 shares@ US$0.34946.7% of flowCommon StockSEC:0001415889-25-008872:0
Ideal exit: 19 Dec 2025 (T+270)
22,038 shares@ US$0.391.1% of flowCommon StockSEC:0001415889-25-007459:0
2,363 shares@ US$0.34210.1% of flowCommon StockSEC:0001415889-24-028743:0
2,363 shares@ US$0.390.1% of flowCommon StockSEC:0001415889-24-023089:0
20,840 shares@ US$0.471.3% of flowCommon StockSEC:0001415889-24-020745:0
782 shares@ US$1.130.1% of flowCommon StockSEC:0001415889-24-018145:0
2,255 shares@ US$1.190.4% of flowCommon StockSEC:0001415889-24-016079:0
20,840 shares@ US$1.173.3% of flowCommon StockSEC:0001415889-24-012091:0
782 shares@ US$2.580.3% of flowCommon StockSEC:0001415889-24-009048:0
50,000 shares@ US$1.909412.6% of flowCommon StockSEC:0001415889-24-007570:0
Ideal exit: 2 Dec 2024 (T+270)
4,209 shares@ US$1.871.0% of flowCommon StockSEC:0001415889-24-007453:0
166,000 shares0Common StockSEC:0001415889-24-005156:0
23,490 shares@ US$2.377.4% of flowCommon StockSEC:0001415889-24-002750:0
819 shares@ US$0.760.1% of flowCommon StockSEC:0001209191-23-059713:0
1,680 shares@ US$0.580.1% of flowCommon StockSEC:0001209191-23-058051:0
21,841 shares@ US$0.54711.6% of flowCommon StockSEC:0001209191-23-054320:0
819 shares@ US$0.78630.1% of flowCommon StockSEC:0001209191-23-050526:0
1,680 shares@ US$0.96310.2% of flowCommon StockSEC:0001209191-23-048815:0
200,000 shares0Common StockSEC:0001209191-23-045215:0
791 shares@ US$16.52971.7% of flowCommon StockSEC:0001209191-23-039700:0
472 shares@ US$17.03561.1% of flowCommon StockSEC:0001209191-23-039157:0
472 shares@ US$17.03561.1% of flowCommon StockSEC:0001209191-23-036066:0
2,343 shares0Common StockSEC:0001209191-23-021539:0
905 shares@ US$18.712.2% of flowCommon StockSEC:0001209191-23-021138:0
6,265 shares@ US$21.155918.1% of flowCommon StockSEC:0001209191-23-018061:0
25 of 43 declarations
About Wettig Thane
Thane Wettig serves as Chief Commercial Officer at FibroGen Inc. He is responsible for leading the company's commercial activities, including business development and sales strategies. With a strong background in the industry, he plays a key role in implementing FibroGen's commercial strategy. Thane Wettig is committed to supporting the company's mission and promoting its growth.
